Sami Corwin
Stock Analyst at William Blair
(0.06)
# 4,393
Out of 5,006 analysts
11
Total ratings
16.67%
Success rate
-25.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sami Corwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KYTX Kyverna Therapeutics | Initiates: Outperform | n/a | $5.89 | - | 1 | Aug 20, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Market Perform | n/a | $23.26 | - | 1 | Jun 20, 2025 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Outperform | $65 | $30.19 | +115.30% | 1 | May 28, 2025 | |
| NKTX Nkarta | Downgrades: Market Perform | n/a | $2.15 | - | 1 | May 15, 2025 | |
| APLT Applied Therapeutics | Downgrades: Market Perform | n/a | $1.02 | - | 1 | Dec 23, 2024 | |
| TNYA Tenaya Therapeutics | Initiates: Outperform | n/a | $1.72 | - | 1 | Jun 10, 2024 | |
| NGNE Neurogene | Initiates: Outperform | n/a | $23.09 | - | 1 | Mar 21, 2024 | |
| MESO Mesoblast | Downgrades: Market Perform | n/a | $17.32 | - | 1 | Aug 4, 2023 | |
| CRSP CRISPR Therapeutics AG | Reinstates: Outperform | $75 | $70.19 | +6.85% | 1 | May 30, 2023 | |
| LEGN Legend Biotech | Initiates: Market Perform | n/a | $31.44 | - | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $66 | $52.91 | +24.74% | 1 | Oct 27, 2021 |
Kyverna Therapeutics
Aug 20, 2025
Initiates: Outperform
Price Target: n/a
Current: $5.89
Upside: -
Sarepta Therapeutics
Jun 20, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $23.26
Upside: -
Ultragenyx Pharmaceutical
May 28, 2025
Initiates: Outperform
Price Target: $65
Current: $30.19
Upside: +115.30%
Nkarta
May 15, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $2.15
Upside: -
Applied Therapeutics
Dec 23, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $1.02
Upside: -
Tenaya Therapeutics
Jun 10, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.72
Upside: -
Neurogene
Mar 21, 2024
Initiates: Outperform
Price Target: n/a
Current: $23.09
Upside: -
Mesoblast
Aug 4, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $17.32
Upside: -
CRISPR Therapeutics AG
May 30, 2023
Reinstates: Outperform
Price Target: $75
Current: $70.19
Upside: +6.85%
Legend Biotech
May 25, 2023
Initiates: Market Perform
Price Target: n/a
Current: $31.44
Upside: -
Oct 27, 2021
Initiates: Outperform
Price Target: $66
Current: $52.91
Upside: +24.74%